drugset / Trial / NCT06816277

Application of Local Melatonin in Peri-implantitis

NCT06816277

Completed 30 enrolled Universidad Complutense de Madrid
RandomizedParallel-groupTriple-blindTreatment

Summary

A randomized clinical trial was carried out in patients affected by peri-implantitis with a follow-up of 60 days. Melatonin 1.9 mg or placebo was applied locally to the peri-implant defect after nonsurgical debridement. To determine the effectiveness anti-inflammatory, osteogenic and antimicrobial properties were evaluated. The probing depth, bleeding index, plaque index, and interleukin-1β and 6 concentrations, peri-implant bone level and the bacterial strains were analyzed.

Timeline

Start
2020-09-01
Primary completion
2023-07-15
Completion
2023-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 1.9 mg Other

Indications